Ken Griffin acquired 856k MaxCyte shares worth $1.19M. That's 0.00% of their equity portfolio (3168th largest holding). The first MaxCyte trade was made in Q4 2021. Since then Ken Griffin bought shares nine more times and sold shares on nine occasions. The investor's estimated purchase price is $2.81M, resulting in a loss of 58%.